Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Journal of Cellular Physiology|September 16, 2024
Interplay between bone marrow adiposity and bone resorption in RANKL-mediated modelled osteoporosisVagelis Rinotas, Evi Gkikopoulou, Efthymiοs Tzortzis, et al.Neurochemical Research|May 20, 2018
Transgenic Mice Carrying GLUD2 as a Tool for Studying the Expressional and the Functional Adaptation of this Positive Selected Gene in Human Brain EvolutionAndreas Plaitakis, Dimitra Kotzamani, Zoe Petraki, et al.Frontiers in Endocrinology|March 16, 2026
Modeling rebound bone loss following denosumab discontinuation and sequential zoledronate therapy in TgRANKL osteoporotic miceVagelis Rinotas, Eleftheria-Dimitra Ntouskou, Melina Dragolia, et al.Current Topics in Medicinal Chemistry|June 8, 2018
Current Status and Future Prospects of Small-molecule Protein-protein Interaction (PPI) Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)Georgia Melagraki, Georgios Leonis, Evangelos Ntougkos, et al.Plos Computational Biology|April 21, 2017
Cheminformatics-aided discovery of small-molecule Protein-Protein Interaction (PPI) dual inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)Georgia Melagraki, Evangelos Ntougkos, Vagelis Rinotas, et al.Plos One|August 12, 2014
A splicing mutation in the novel mitochondrial protein DNAJC11 causes motor neuron pathology associated with cristae disorganization, and lymphoid abnormalities in miceFotis Ioakeimidis, Christine Ott, Vera Kozjak-Pavlovic, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 16, 2013
Novel genetic models of osteoporosis by overexpression of human RANKL in transgenic miceVagelis Rinotas, Alexandra Niti, Romain Dacquin, et al.International Journal of Molecular Sciences|June 13, 2025
RANKL Drives Bone Metastasis in Mammary Cancer: Protective Effects of Anti-Resorptive TreatmentsEvi Gkikopoulou, Christos-Chrysovalantis Syrigos, Ioanna Mantogiannakou, et al.Journal of Medicinal Chemistry|September 21, 2020
Discovery of Small-Molecule Inhibitors of Receptor Activator of Nuclear Factor-κB Ligand with a Superior Therapeutic IndexVagelis Rinotas, Athanasios Papakyriakou, Foteini Violitzi, et al.International Journal of Molecular Sciences|July 29, 2023
Structure-Based Discovery of Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-Induced Osteoclastogenesis InhibitorsVagelis Rinotas, Fotini Liepouri, Maria-Dimitra Ouzouni, et al.Pageof 3